Uterine Fibroid Treatment Devices Market Analysis By Development Trends, Business Share, Opportunities, Segmentation and Forecast to 2018 – 2026

                                                                                 
Uterine fibroid embolization (UFE) is a minimally invasive procedure for treating uterine fibroid tumours.

Uterine Fibroid Treatment Devices Market



Uterine fibroid embolization (UFE) is a minimally invasive procedure for treating uterine fibroid tumours. The procedure of uterine fibroid embolization is also known as uterine artery embolization (UAE). Other issues treated with UFE include placenta accreta, placenta previa, and pelvic arteriovenous malformations. The most frequent benign tumour growths in the uterine walls (intramural fibroids), within the uterine cavity (sub mucosal fibroids), or on the serosal surface of the uterus are uterine fibroids (subserosal fibroids). These fibroid tumours, also known as myomas, are extremely unlikely to become malignant tumours. Heavy menstrual blood, pain in the back of the legs, anaemia, constipation, pain in the pelvic region, pressure on the bowel or bladder, and other debilitating symptoms are all symptoms linked with these utreal fibroid tumours. Uterine fibroids afflict approximately 20% to 40% of women over the age of 35.

A growing population of uterine fibroid patients, technological advancements in the field of uterine/endometrial ablation and laparoscopic devices, a growing number of hospitals and surgical centres, and growing awareness about minimally invasive and non-invasive procedures to treat uterine fibroids are all driving the global Uterine Fibroid Treatment Devices Market. However, strong cost-cutting efforts implemented by various governments, as well as ongoing healthcare changes in the United States, are limiting this market.


Market Segmentation:

By Mode of Treatment
  • Invasive Treatment
  • Minimally Invasive Treatment
  • Non-Invasive Treatment

By Technology Type
  • Surgical techniques
  • Laparoscopic techniques
  • Ablation Techniques
  • Embolization Techniques

By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Center

In the United Kingdom, 30,929 persons were diagnosed with uterine fibroid by hospital consultants in the years 2012–2013, which is likely to fuel the growth of the Uterine Fibroid Treatment Devices Market. According to the National Uterine Fibroids Foundation, approximately 12 hysterectomies were performed every 10 minutes in the United States in 2010, with around 600,000 hysterectomies performed annually in the United States, of which around 170,000 – 300,000 were performed due to uterine fibroids, indicating that the Uterine Fibroid Treatment Devices Market will grow in the near future.

The key players operating in Uterine Fibroid Treatment Devices Market includes Advanced Surgical Concepts, PLLC, Boston Scientific Corporation, CONMED Corporation, CooperSurgical, Inc., Ethicon, Inc., Hologic, Inc., Medtronic, Plc, Olympus Corporation, PENTAX Medical, and Stryker Corporation.

Source Link: https://www.medgadget.com/2020/12/uterine-fibroid-treatment-devices-market-size-overview-share-value-global-trends-growth-insights-industry-analysis-and-forecast-to-2025-by-cmi.html

Comments

Post a Comment

Popular posts from this blog

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the...
Read more

Aromatherapy Market: A Scent-Sational Journey to Wellness and Market Growth

Image
  Aromatherapy Market Introduction : Aromatherapy, a holistic approach to healing that utilizes essential oils extracted from plants, has gained significant popularity in recent years. Its therapeutic benefits and relaxing properties have captured the attention of individuals seeking alternative wellness solutions. This report explores the dynamic growth of the aromatherapy market, highlighting key trends, drivers, and challenges shaping its trajectory. Market Overview : The global Aromatherapy Market has experienced remarkable growth in recent years, driven by the increasing demand for natural and organic products in the wellness industry. The market encompasses a wide range of products, including essential oils, diffusers, candles, and massage oils. With the rising consumer inclination towards stress reduction, relaxation, and self-care, aromatherapy has emerged as a powerful tool for achieving physical and mental well-being. Key Market Trends: Growing Awareness a...
Read more

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.

Image
The material having tiny uniformly sized holes is known as a molecular sieve. Angstroms or nanometers are the units of measurement for molecular sieves (nm). Microporous (2 nm), macroporous (50 nm), and mesoporous molecular sieves are all available (2 nm- 50 nm). Zeolites, crystalline alumino-silicates, are used to make Molecular Sieves. Three-dimensional pore systems were used to describe molecular sieves crystals, and the identical crystals were recognised as a group. Commercially available absorbents are basic Molecular sieves kinds A and X. As absorbents for fluids, molecular sieves are utilised (gas and liquids). Fluids can be separated using molecular sieve absorbents based on their size and polarity. When it comes to hydrocarbons, there are a number of factors to consider. Molecule sieve absorbents may separate liquids based on their molecular size and polarity. Straight molecules fit into pores and are absorbed in the case of hydrocarbon parafines. The branching molecules are...
Read more